Want to see VTR full AI Analyst Report?
Ventas (VTR) AI Stock Analysis
Ventas
(NYSE:VTR)
The score is driven primarily by improving financial performance (notably strong and growing free cash flow) and a very constructive earnings outlook with raised guidance and strong SHOP operating momentum. These strengths are tempered by weak technical momentum and an expensive valuation (very high P/E), with additional caution from leverage and reporting volatility in gross profit/debt presentation.
Ventas Key Performance Indicators (KPIs)
Revenue by TypeSeparates revenue into categories like contractual rent, operating income from managed communities, and fees, clarifying which cash flows are recurring versus variable. For investors in Ventas, this helps judge dividend sustainability and the sensitivity of revenue to occupancy, reimbursement, or management performance.
Resident Fees & Services is the clear growth engine—accelerating sharply and driving the company’s revenue and NOI, a trend that underpins management’s raised FFO and heavier SHOP investment posture. Rental Income is steady but non‑growthary, while loan/investment and office-related lines are small and volatile. Ventas is redeploying capital into senior housing and active asset management to monetize occupancy and rate gains; execution risk remains around lease‑ups and near‑term capex, but the current operational momentum supports margin expansion and FFO upside if occupancy improvements persist.
The FlyVentas (VTR) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $46.03B
- Dividend Yield
- 2.34%
- Average Volume (3M)
- 3.58M
- Price to Earnings (P/E)
- 161.2
- Beta (1Y)
- 0.17
- Revenue Growth
- 22.13%
- EPS Growth
- 0.00%
- Country
- US
- Employees
- 542
- Sector
- Real Estate
- Sector Strength
- 65
- Industry
- REIT - Healthcare Facilities
Ventas Business Overview & Revenue Model
Company Description
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity ec...
How the Company Makes Money
Ventas makes money primarily by generating recurring real estate income from its healthcare property portfolio. Key revenue streams include: (1) Rental and lease income: For properties operated under triple-net or other lease arrangements, Ventas ear...
Ventas Earnings Call Summary
The call was strongly positive, characterized by record company same-store growth, 17 consecutive quarters of double-digit SHOP NOI growth, improving occupancy and margins, increased FFO guidance, substantial investment activity, stronger leverage, and a robust acquisition pipeline. The company cited limited challenges from research portfolio performance, quarterly utility costs, higher interest rates, FX, acquisition competition, and lower-priority international markets, but these did not outweigh the reported operating momentum and outlook.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Ventas raised full year net income guidance to $0.64 to $0.67 per share or $0.66 per share at the midpoint, and increased full year normalized FFO per share guidance to now range from $3.87 to $3.90 per share, which represents year over year growth of 9% to 10%; the guidance includes closed investments of $5.2 billion, assumes refinancing maturing debt in the coming months, and expects the majority of disposition and loan repayment guidance of $700 million at a 7% yield to close in the fourth quarter. Same store cash NOI guidance was reaffirmed for each segment and for the total company. Senior housing investments are expected to produce double digit to mid teens unlevered IRRs and year-1 average yields in the mid-6s, while next year’s in house rent increases are expected to be around the same or better.
Ventas Financial Statement Overview
Summary
Fundamentals are improving with meaningful revenue acceleration, a return to positive net income, and strong, rising operating and free cash flow that supports dividends and reinvestment. Offsetting this are balance-sheet concerns (historically elevated leverage and an unclear TTM debt presentation) and volatility/oddities in reported gross profit that add uncertainty to earnings quality.
Income Statement
71PositiveBalance Sheet
62PositiveCash Flow
84Very Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.78B | 5.83B | 4.92B | 4.50B | 4.13B | 3.83B |
| Gross Profit | -60.12M | -344.22M | 2.10B | 1.94B | 1.85B | 1.74B |
| EBITDA | 2.59B | 2.24B | 1.82B | 1.70B | 1.50B | 1.48B |
| Net Income | 265.60M | 251.38M | 81.15M | -40.97M | -47.45M | 49.01M |
Balance Sheet | ||||||
| Total Assets | 30.63B | 27.59B | 26.19B | 24.73B | 24.16B | 24.72B |
| Cash, Cash Equivalents and Short-Term Investments | 202.01M | 741.07M | 897.85M | 508.79M | 122.56M | 149.72M |
| Total Debt | 12.67B | 13.22B | 13.74B | 13.69B | 12.49B | 12.22B |
| Total Liabilities | 14.27B | 15.01B | 15.36B | 15.18B | 13.94B | 13.77B |
| Stockholders Equity | 15.81B | 12.53B | 10.77B | 9.49B | 10.15B | 10.85B |
Cash Flow | ||||||
| Free Cash Flow | 1.66B | 1.32B | 1.06B | 935.13M | 926.34M | 858.69M |
| Operating Cash Flow | 1.95B | 1.68B | 1.34B | 1.19B | 1.15B | 1.04B |
| Investing Cash Flow | -4.78B | -2.73B | -2.39B | -239.20M | -882.33M | -764.48M |
| Financing Cash Flow | 2.82B | 875.73M | 1.45B | -563.88M | -289.13M | -535.97M |
Ventas Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VTR, the sentiment is Positive. The current price of 87.04 is above the 20-day moving average (MA) of 84.53, above the 50-day MA of 86.61, and above the 200-day MA of 85.78, indicating a bullish trend. The MACD of -0.10 indicates Negative momentum. The RSI at 55.10 is Neutral, neither overbought nor oversold. The STOCH value of 83.15 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VTR.
Ventas Risk Analysis
Ventas disclosed 52 risk factors in its most recent earnings report. Ventas reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksVentas Peers Comparison
Overall Rating
CTRE80Outperform
OHI80Outperform
DOC70Outperform
WELL70Outperform- VTR67Neutral
HR60Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| CTRE | 80Outperform | $8.54B | 22.80 | 8.54% | 4.10% | 53.07% | 32.48% |
| OHI | 80Outperform | $14.24B | 21.03 | 16.51% | 5.66% | 15.18% | 72.69% |
| DOC | 70Outperform | $13.76B | 36.22 | 5.00% | 6.24% | 9.42% | ― |
| WELL | 70Outperform | $175.33B | 116.51 | 3.23% | 1.27% | 39.11% | -140.16% |
| VTR | 67Neutral | $46.85B | 161.19 | 1.89% | 2.34% | 22.13% | 0.00% |
| Sector * | 65Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |
| HR | 60Neutral | $6.47B | -134.78 | -1.04% | 5.01% | -6.28% | 77.63% |
* Real Estate Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| VTR | Ventas Inc | 87.04 | 13.86 | 18.94% | |
| DOC | Healthpeak Properties, Inc. | 19.56 | 2.83 | 16.92% | |
| WELL | Welltower, Inc. | 241.17 | 57.52 | 31.32% | |
| OHI | Omega Healthcare Investors | 47.53 | 6.31 | 15.32% | |
| HR | Healthcare Realty Trust Incorporated | 19.18 | 2.14 | 12.53% | |
| CTRE | CareTrust REIT | 36.71 | 2.12 | 6.14% |
Ventas Corporate Events
Ventas Appoints Laurida Sayed as Chief Accounting Officer
PositiveOn September 10, 2026, Ventas, Inc. approved the appointment of Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, effective on or around October 5, 2026, with Executive Vice President and Chief Financial Officer Robert...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 29, 2026